Notable healthcare headlines for the week: CVS, Eli Lilly and Novartis in focus

businessinsider
2025.12.14 14:16

Wall Street's major averages fell, with healthcare stocks showing gains. CVS Health set a 2026 revenue outlook below consensus but increased 2025 guidance. Eli Lilly's weight loss therapy succeeded in trials. Novartis signed a $1.7 billion agreement with Relation Therapeutics for drug targets. Pfizer plans job cuts in Switzerland amid restructuring. Trump is expected to sign an executive order to reclassify marijuana as a less dangerous drug.

Source: businessinsider The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
© 2025 Longbridge｜Disclaimer